Pain response and clinical outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223): Final results from a prospective, noninterventional study (PARABO)

Autor: H. Palmedo, S. Eschmann, A. Niesen, J. Schönberger, V. Barsegian, K. Liepe, F.M. Mottaghy, R. Guan, J. Pinkert, K. Herrmann
Rok vydání: 2022
Zdroj: 60. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
ISSN: 2567-6407
DOI: 10.1055/s-0042-1746058
Databáze: OpenAIRE